nuMetrix
Beyond the Numbers
We talk about money. CHF millions. Revenue leakage.
But behind every financial anomaly
is a patient. And a person who cares for them.
The Surface
We built a diagnostic system.
It finds millions.
CHF 30M
financial anomalies
detected at SZO
27
automated probes
running continuously
The CFO listens. The board nods. The numbers are impressive.
But this is not the story.
The Question
What does a “finding”
actually mean?
A finding is not a number on a dashboard.
It is something that happened —
or failed to happen — to a real person.
Act I
The Patient
Behind every data anomaly is someone who trusted a hospital with their life.
The Missing Implant
A hip replacement.
No implant in the usage log.
Financial
CHF 2,500 at risk. A billing gap. A documentation deficiency.
Patient
A patient who cannot be found if their prosthesis is recalled. No record of what was implanted. No way to contact them. No way to protect them.
The probe sees a missing record.
The patient has a hip they trust will last 20 years.
If the manufacturer issues a recall — the hospital has no list.
The Invisible Flow
437,034 units.
Zero patient attribution.
What the data says
Material 620260 at SZO.
437,034 units transferred from
warehouse to ward over 36 months.
Zero documented as used on a patient.
CHF 17.8M in material flow with no attribution.
What it means
If this material is subject to a safety recall tomorrow,
there is no patient list.
Not because the hospital is negligent.
Because the system does not require it.
The gap is invisible until you look.
The Stale Catalogue
CHF 3.1M in expired oncology entries.
Still actively administered.
- Opdivo 240mg — CHF 879K billed against a catalogue entry that expired 18 months ago. Immunotherapy. A nurse looking up dosing information works from stale data.
- Pelgraz 6mg — CHF 394K. The catalogue entry references an old formulation. If the approved indications changed, clinical staff may not know.
- Ibrance 125mg — CHF 220K. High-cost oncology capsules. Expired entries may carry superseded contraindication warnings.
The probe detects a billing risk. The clinical reality:
care decisions are being made with outdated reference data.
The Proof
The OR tracks at 100%.
The ward tracks at 31%.
Operating Room
I/O coefficient ≈ 1.0
Every suture, every IV bag, every drug vial
documented per patient. Because anaesthesia
and surgical protocols require it.
The capability exists.
General Ward
I/O coefficient ≈ 0.31
For every 100 units sent to the ward,
only 31 are attributed to a patient.
Rational under DRG lump-sum billing.
But not neutral for patient safety.
The gap is not a limitation. It is a choice.
The OR proves the capability. The ward reveals the trade-off.
Act II
The Career
Behind every compliance gap is a person who carries the risk.
Controlled Substances
Not an institutional compliance risk.
A personal criminal liability.
Financial
Unaccounted stock. Reconciliation gap. Regulatory finding in the next audit.
Career
The Narcotics Act (BtMG) makes individuals personally liable. The pharmacist. The ward nurse. The department head. Named people. Not the institution.
At SZO, the controlled substance field is 0% populated.
The probe cannot run. The gap is not detected — it is invisible.
Which is worse than a confirmed finding.
The Nurse
She is not a fraudster.
She is not negligent.
She is following a rational workflow
in a constrained system.
A ward nurse who doesn't scan every IV bag
is not doing something wrong. She is doing what the system allows.
The gap is not personal. The gap is systemic.
But when something goes wrong —
the investigation looks at individuals.
Context Changes Everything
A billing event timestamped
before the material was used.
In an audit
A data entry error.
A clock synchronisation issue.
A rounding artefact.
Severity: medium.
Explanation: technical.
In litigation
Evidence of record manipulation.
A charge created to justify a cost
that had not yet been incurred.
Severity: career-ending.
Explanation: required under oath.
The same data point. Two interpretations.
The difference is who is asking — and why.
Act III
The Bridge
From financial detection to clinical protection.
The Conversation
Every financial anomaly
is a clinical safety conversation
waiting to happen.
- The revenue leakage finding leads to a floor conversation with the ward about scanning workflows.
- That conversation changes documentation practices — what gets recorded, when, by whom.
- Those practices determine whether the next patient's care is fully traceable.
- The financial fix and the patient safety improvement are the same intervention.
The Network
Shared learning.
No single hospital learns fast enough.
A
Hospital A
Detects a billing workflow gap. Retrains ward staff on scanner protocols. Documentation improves. Finding disappears in 3 weeks.
B
Hospital B
Same diagnosis appears. The system suggests: “Hospital A resolved this via staff retraining — 3 weeks, effective.”
N
The Network
Every resolved diagnosis becomes institutional knowledge. Financial interventions that also protect patients — shared across the system.
The Shield
The diligent deserve evidence.
When the audit comes. When the recall happens.
When the litigation starts.
Who has the documentation?
A hospital that runs systematic, automated, reproducible
diagnostic checks can demonstrate due diligence.
A hospital that relies on year-end manual reconciliation cannot.
nuMetrix provides the evidence chain
that protects the people who do the right thing.
Without Blame
The system flags anomalies.
It does not assign blame.
A probe detects the gap. A diagnosis attributes it to
process failure, system failure, or structural misalignment.
The treatment layer prescribes investigation — not punishment.
Learning without blame. Evolution without accusation.
Decisions without pretending certainty.
The Point
Why We Do This
It was never just about the money.
What We Protect
Three things. In this order.
1
Lives
Patients who trust
hospitals with their bodies
2
Careers
Nurses, pharmacists, doctors
who carry the daily risk
3
Money
The resource that enables
everything above
The money matters because it funds the care.
The career matters because it sustains the people.
The life matters because it is the reason we are here.
nuMetrix
The money is the symptom.
The patient is the point.
Every probe we build. Every hypothesis we test.
Every diagnosis we explain.
It all flows toward the same thing:
making the invisible visible —
so that the people who care for patients
can do so with better data, better systems,
and the evidence to prove they tried.